From our sister publication, Managed Healthcare Executive®: As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings.
From our sister publication, Managed Healthcare Executive®: Biosimilars hold great cost savings promises for payers and patients alike—but only if prescribers and patients are willing to make the switch.
